Dr. Reddy’s launches generic of OTC Prevacid
Dr. Reddy’s is debuting lansoprazole delayed-release capsules in a dosage strength of 15 mg.
The product is a generic OTC version of Takeda’s Prevacid 24HR capsules.
Dr. Reddy’s OTC lansoprazole is a proton pump inhibitor used to treat frequent heartburn occurring two or more days a week. It is available in 14, 28 and 42 count sizes.
"We are pleased to continue to expand our antacids and PPI portfolio for our customers,” Dr. Reddy’s senior vice president and head of U.S. OTC and specialty rx divisions Milan Kalawadia said, adding, “We look forward to collaborating with our customers to provide high-quality, affordable alternatives to consumers.”
The Prevacid 24HR brand and generic had a maket value of approximately $57 million for the most recent 12 months ended August 2019, according to IQVIA.
The product is a generic OTC version of Takeda’s Prevacid 24HR capsules.
Dr. Reddy’s OTC lansoprazole is a proton pump inhibitor used to treat frequent heartburn occurring two or more days a week. It is available in 14, 28 and 42 count sizes.
"We are pleased to continue to expand our antacids and PPI portfolio for our customers,” Dr. Reddy’s senior vice president and head of U.S. OTC and specialty rx divisions Milan Kalawadia said, adding, “We look forward to collaborating with our customers to provide high-quality, affordable alternatives to consumers.”
The Prevacid 24HR brand and generic had a maket value of approximately $57 million for the most recent 12 months ended August 2019, according to IQVIA.